Claritev Profit Margin

The latest profit margin for CTEV is -28.46% as of June 2026. That compares with -70.91% in the prior-year period — up 59.9% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Claritev's historical trend and sector peers before judging valuation or financial health.

Over the past year, CTEV's profit margin moved from -70.91% to -28.46% — a 59.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Claritev's valuation or profitability profile.

Against Healthcare companies, CTEV currently prints -28.46% for profit margin, while the sector average sits near 19.13%. That is roughly 248.8% below the sector mean. Large gaps often invite a closer look at Claritev's growth, margins, and balance sheet.

Profit Margin shows how effectively Claritev converts resources into returns. At -28.46%, CTEV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -70.91% in the prior-year period — up 59.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CTEV's profit margin (-28.46%), review year-over-year change from -70.91%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.